Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.
Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check18 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference0.6%
- Check25 days agoChange DetectedThe website has added new content, while a significant study comparing antiretroviral treatments for HIV-1 has been removed.SummaryDifference2%
- Check32 days agoChange DetectedThe website has added a 'Show less' feature while removing detailed options related to participant groups, interventions, and various data fields for downloads.SummaryDifference0.9%
- Check39 days agoChange DetectedSeveral key health-related resources have been removed, including links to MedlinePlus and various drug information pages on DailyMed, which may impact access to important medical information.SummaryDifference0.2%
- Check47 days agoChange DetectedThe website has added several new resources related to HIV and viral infections, including links to MedlinePlus and DailyMed for specific medications like Lamivudine and Tenofovir, while updating the revision from v2.12.1 to v2.12.2.SummaryDifference1%
Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.